Prostasin (PRSS8), GSTT1, FOLR1, KLK6, KLK7, and ALDH1 are all currently under research and clinical trials (Table 2) and are also potential biomarkers for early detection of ovarian cancer. This evidence concerns the gene FOLR1 and ovarian carcinoma.